RE:RE:RE:Why wasn't 90 a "Major Catalyst"?I am all for deeper discussions with other parties/ potential buyers. But let's be honest, any discussions on paying ~$1Billion + dollars for PMX starts with- look at the trial's crude data, look how good the numbers are and how low the risk is.
If they stick with their statement and their "deal" with Baxter- that they will not share crude data until they share it with Baxter at trial completion.
How could they sell? How could someone buy?
There is no chance for constantly repeated major catalyst until the end of the trial or final approval.